Sigma receptors inhibit high-voltage-activated calcium channels in rat sympathetic and parasympathetic neurons.
Studies on the expression and cellular function of sigma receptors in autonomic neurons were conducted in neonatal rat intracardiac and superior cervical (SCG) ganglia. Individual neurons from SCG and intracardiac ganglia were shown to express transcripts encoding the sigma-1 receptor using single-cell RT-PCR techniques. The relationship between sigma receptors and calcium channels was studied in isolated neurons of these ganglia under voltage-clamp mode using the perforated-patch configuration of the whole cell patch-clamp recording technique. Bath application of sigma receptor agonists was shown to rapidly depress peak calcium channel currents in a reversible manner in both SCG and intracardiac ganglion neurons. The inhibition of barium (I(Ba)) currents was dose-dependent, and half-maximal inhibitory concentration (IC50) values for haloperidol, ibogaine, (+)-pentazocine, and 1,3-Di-O-tolylguanidin (DTG) were 6, 31, 61, and 133 microM, respectively. The rank order potency of haloperidol > ibogaine > (+)-pentazocine > DTG is consistent with the effects on calcium channels being mediated by a sigma-2 receptor. Preincubation of neurons with the irreversible sigma receptor antagonist, metaphit, blocked DTG-mediated inhibition of Ca2+ channel currents. Maximum inhibition of calcium channel currents was > or =95%, suggesting that sigma receptors block all calcium channel subtypes found on the cell body of these neurons, which includes N-, L-, P/Q-, and R-type calcium channels. In addition to depressing peak Ca2+ channel current, sigma receptors altered the biophysical properties of these channels. Following sigma receptor activation, Ca2+ channel inactivation rate was accelerated, and the voltage dependence of both steady-state inactivation and activation shifted toward more negative potentials. Experiments on the signal transduction cascade coupling sigma receptors and Ca2+ channels demonstrated that neither cell dialysis nor intracellular application of 100 microM guanosine 5'-O-(2-thiodiphosphate) trilithium salt (GDP-beta-S) abolished the modulation of I(Ba) by sigma receptor agonists. These data suggest that neither a diffusible cytosolic second messenger nor a G protein is involved in this pathway. Activation of sigma receptors on sympathetic and parasympathetic neurons is likely to modulate cell-to-cell signaling in autonomic ganglia and thus the regulation of cardiac function by the peripheral nervous system.
Zhang
Hongling
H
Department of Pharmacology and Therapeutics, University of South Florida College of Medicine, Tampa, Florida 33612, USA.
Cuevas
Javier
J
D000701:Analgesics, Opioid / Q000494:pharmacology; D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism; D015220:Calcium Channels / Q000378:metabolism*; D002478:Cells, Cultured; D018492:Dopamine Antagonists / Q000494:pharmacology; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology; D005726:Ganglia, Parasympathetic / Q000166:cytology*; D015870:Gene Expression / Q000502:physiology; D006146:Guanidines / Q000494:pharmacology; D006153:Guanosine Diphosphate / Q000031:analogs & derivatives* / Q000494:pharmacology; D006160:Guanosine Triphosphate / Q000494:pharmacology; D006220:Haloperidol / Q000494:pharmacology; D007050:Ibogaine / Q000494:pharmacology; D015640:Ion Channel Gating / Q000187:drug effects / Q000502:physiology; D008564:Membrane Potentials / Q000187:drug effects / Q000502:physiology; D017551:Microdialysis; D009474:Neurons / Q000502:physiology*; D010423:Pentazocine / Q000494:pharmacology; D012333:RNA, Messenger / Q000032:analysis; D051381:Rats; D017480:Receptors, sigma / Q000235:genetics / Q000378:metabolism*; D015398:Signal Transduction / Q000502:physiology; D017783:Superior Cervical Ganglion / Q000166:cytology*; D013873:Thionucleotides / Q000494:pharmacology
D000701:Analgesics, Opioid; D000927:Anticonvulsants; D015220:Calcium Channels; D018492:Dopamine Antagonists; D018691:Excitatory Amino Acid Antagonists; D006146:Guanidines; D012333:RNA, Messenger; D017480:Receptors, sigma; D013873:Thionucleotides; D006153:Guanosine Diphosphate; D007050:Ibogaine; C023427:guanosine 5'-O-(2-thiodiphosphate); D006160:Guanosine Triphosphate; D006220:Haloperidol; C050232:1,3-ditolylguanidine; D010423:Pentazocine; D002118:Calcium